Concert AI is an AI-driven platform for oncology research and data analytics, providing insights from lab results, oncology practice visits, tumor observations, vitals, medications, comorbidities, budgets, and other clinical data. The platform enables real-time patient matching to clinical trials and collaborates with biopharma companies to accelerate research and treatment development. Concert AI has raised $300M in funding from investors including Sixth Street and Declaration Partners, with a current valuation of $1.9B (as of March 29, 2022).
What Is Concert AI and What Does It Do?
Concert AI, founded in 2018, is headquartered in Boston, Massachusetts. The company specializes in leveraging artificial intelligence to provide comprehensive oncology data and insights for research and clinical decision-making.
The platform aggregates data such as lab results, tumor-related observations, vitals, medications, biometric pain metrics, diagnosis states, and treatment costs. It enables real-time patient matching to clinical trials, helping biopharma and healthcare organizations optimize research and deliver precision oncology solutions.
With a team of 501-1,000 employees, Concert AI empowers researchers and clinicians to accelerate cancer care innovation while improving patient outcomes.
How Much Funding Has Concert AI Raised?
1. Series B
- Amount Raised: $150M
- Date: January 2020
- Lead Investors: Declaration Partners, Maverick Ventures, AllianceBernstein, SymphonyAI
- Motivation: To scale AI-driven oncology research capabilities and expand clinical trial matching solutions.
2. Series C
- Amount Raised: $150M
- Date: March 2022
- Lead Investors: Sixth Street
- Motivation: To accelerate platform growth, enhance AI analytics capabilities, and expand collaborations with biopharma companies.
Total Funding Raised: $300 Million
Current Valuation: $1.9 Billion (as of March 2022)
Latest Funding Date: March 2022
Key Investors
1. Sixth Street
- Details: Global investment firm focusing on growth-stage technology and healthcare companies.
- Investment Focus Areas: Technology, healthcare, AI-driven platforms
- Notable Investments: Concert AI, various healthcare and fintech ventures
2. Declaration Partners
- Details: Venture firm investing in transformative healthcare and life sciences companies.
- Investment Focus Areas: Healthcare, biotech, AI in life sciences
- Notable Investments: Concert AI, Precision Medicine initiatives
3. Maverick Ventures
- Details: Early-stage venture capital firm supporting innovative healthcare and technology startups.
- Investment Focus Areas: Healthcare, digital health, AI
- Notable Investments: Concert AI, clinical research platforms
Where Is Concert AI’s Headquarters?
Concert AI is headquartered in Boston, Massachusetts, a leading hub for biotechnology, healthcare innovation, and AI research. The location provides access to top academic institutions, a skilled talent pool, and collaboration opportunities with hospitals, research centers, and biopharma companies.
What’s Next for Concert AI?
With $150M raised in Series C funding, Concert AI is positioned to expand its AI-driven oncology platform, deepen clinical trial collaborations, and provide more comprehensive data solutions for life sciences companies. Future growth opportunities include global expansion, integration with additional healthcare systems, and the development of predictive analytics tools to accelerate cancer treatment and research. Challenges include navigating regulatory compliance, maintaining data privacy, and competing in the rapidly evolving AI-driven healthcare market.
Get Investor & Funding Insights with TexAu
TexAu helps sales and business teams uncover detailed fundraising information on companies like Concert AI. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.
Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.
